Carregant...
Utilization of Biomarkers in Lupus Nephritis
Lupus nephritis (LN), occurs in up to 60% of SLE patients, and is a leading cause of disability and death. Current treatment of LN consists of a combination of high dose corticosteroids that non-specifically decrease inflammation and cytotoxic medications that reduce autoantibody production. That co...
Guardat en:
| Publicat a: | Adv Chronic Kidney Dis |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7001747/ https://ncbi.nlm.nih.gov/pubmed/31733719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ackd.2019.09.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|